Insider Trading History of Flynn Daniel Lee


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Flynn Daniel Lee since year 2005. The trader's CIK number is 1713712. At the time of the last reporting, Flynn Daniel Lee was the Chief Scientific Officer of Deciphera Pharmaceuticals, Inc. . (stock ticker symbol DCPH). See this page for all insider trading activities at Deciphera Pharmaceuticals, Inc. .


Stock purchases, sales, and option exercises reported by insider Flynn Daniel Lee since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-08-13 DCPH Deciphera Pharmaceuticals, Inc. Sale 148,107 41.50 6,145,996
2019-08-13 DCPH Deciphera Pharmaceuticals, Inc. Option Ex 123,107 1.89 232,672
2019-02-21 DCPH Deciphera Pharmaceuticals, Inc. Option Ex 24,500 3.95 96,775
2019-01-16 DCPH Deciphera Pharmaceuticals, Inc. Sale 152,629 26.00 3,968,354
2019-01-16 DCPH Deciphera Pharmaceuticals, Inc. Option Ex 152,629 1.89 288,468
2019-01-11 DCPH Deciphera Pharmaceuticals, Inc. Sale 300 26.00 7,800
2019-01-11 DCPH Deciphera Pharmaceuticals, Inc. Option Ex 300 1.89 567

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Flynn Daniel Lee (Chief Scientific Officer of Deciphera Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.